Biotechnology

Aeterna Zentaris

$0.6832
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.0245 (-3.46%) As of 3:04 PM UTC today

Why Robinhood?

You can buy or sell AEZS and other stocks, options, and ETFs commission-free!

About AEZS

Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC. The listed name for AEZS is Aeterna Zentaris Inc. Common Stock.

CEO
Klaus Wolfgang Paulini
Employees
11
Headquarters
Charleston, South Carolina
Founded
1990
Market Cap
40.60M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
12.12M
High Today
$0.7296
Low Today
$0.6703
Open Price
$0.7199
Volume
2.84M
52 Week High
$1.38
52 Week Low
$0.29

Collections

AEZS Earnings

-$0.15
-$0.09
-$0.02
$0.04
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 30, Pre-Market

You May Also Like

DLR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure